Valuation (43%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 40.59 | 33.55 |
| PEG Ratio (TTM) | 5.05 | 2.38 |
| P/S Ratio (TTM) | 8.31 | 14.25 |
| P/B Ratio (TTM) | 39.54 | 17.30 |
| P/FCF Ratio (TTM) | 39.68 | 41.23 |
| Price to 5YR AVG Earnings Ratio | 46.70 | 20.06 |
| Price to 5YR AVG FCF Ratio | 44.16 | 56.82 |
Profitability (70%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 7.61% | 12.85% |
| ROE (TTM) | 146.49% | -4.45% |
| Net Profit Margin (TTM) | 20.40% | 26.19% |
| ROIC 5YR AVG | 21.90% | 5.25% |
Growth (50%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 5.47% | 1.57% | 10.43% |
| Revenue | 1.82% | 2.45% | 6.21% |
| Net Income | 5.87% | -8.02% | 5.13% |
| Cash Flow | 915.98% | -9.58% | 12.00% |
Health (33%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 0.72 | 1.37 |
| Quick Ratio (TTM) | 0.72 | 1.35 |
| D/E Ratio (TTM) | 7.50 | 1.14 |
| Interest Coverage (TTM) | 9.02 | 39.49 |
| Piotroski F-Score | 6 | 6 |
| Altman Z-Score | 2.44 | 8.81 |
| LTL to 5YR AVG FCF | 7.53 | 5.48 |
| Shares Outstanding Growth 5YR AVG | -5.32% | 0.21% |